PharmEasy's Shocking Valuation Drop: $5.6B to $456M! • Once valued at $5.6 billion, PharmEasy is now worth only about $456 million. • This major fall in valuation is because one of PharmEasy's investors, Janus Henderson Investors, indicated in a report that they believe the company is now worth less. • API Holdings, the parent company of PharmEasy, posted a loss of ₹2,533 crore in fiscal year 2024 (FY24). The company's revenue fell by 15%, dropping to ₹5,664 crore from ₹6,644 crore in FY23. • Although PharmEasy's parent company raised around $1 billion in funding from various funds, such as Prosus Ventures, Temasek, Bessemer Venture Partners, and Goldman Sachs, etc.
Download the medial app to read full posts, comements and news.